Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518932 | 0.88 | NAAA (0.36) | NAAAOPRD1ALDH1A1HTTEPHX2 | |
| SCHEMBL6518207 | 0.85 | NAAA (0.34) | NAAAALDH1A1EPHX1 | |
| SCHEMBL6516569 | 0.85 | CES2 (0.37) | NAAAALDH1A1EPHX1HPGDEPHX2 | |
| SCHEMBL6515569 | 0.83 | HDAC8 (0.33) | ALDH1A1EPHX1HPGD | |
| SCHEMBL6523763 | 0.82 | POLB (0.38) | ALDH1A1HTTEPHX2POLBKMT2A | |
| SCHEMBL6520379 | 0.82 | NAAA (0.44) | NAAAABL1RIN1EPHX1EPHX2 | |
| SCHEMBL6520371 | 0.82 | NAAA (0.44) | NAAAABL1RIN1EPHX1EPHX2 | |
| SCHEMBL6522620 | 0.80 | ALDH1A1 (0.32) | ALDH1A1HPGDEPHX2KMT2A | |
| SCHEMBL6517109 | 0.80 | NAAA (0.54) | NAAAOPRD1ALDH1A1HTTEPHX1 | |
| SCHEMBL675244 | 0.78 | AKR1B1 (0.44) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | NAAA 2110/4885OPRD1 814/4885ABL1 2916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.